Treatment outcomes for older patients with relapsed/ refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: A subgroup analysis from the phase III CCTG LY.12 trial

Kelly Davison, B. E. Chen, V. Kukreti, S. Couban, A. Benger, N. L. Berinstein, L. Kaizer, P. Desjardins, J. Mangel, L. Zhu, M. S. Djurfeldt, A. E. Hay, L. E. Shepherd, M. Crump

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)622-627
Number of pages6
JournalAnnals of Oncology
Volume28
Issue number3
DOIs
Publication statusPublished - Mar 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Oncology

Keywords

  • Autologous transplant
  • Elderly
  • Non-Hodgkin lymphoma
  • Relapse
  • Salvage chemotherapy

Fingerprint

Dive into the research topics of 'Treatment outcomes for older patients with relapsed/ refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: A subgroup analysis from the phase III CCTG LY.12 trial'. Together they form a unique fingerprint.

Cite this